terminal hip flexion (83 vs. 92 , p ¼ 0.011) and internal rotation (0.5 vs. 6.4 , p < 0.001) on the operative side compared to controls. Radiographic lateral center-edge angle (41 vs. 31 , p ¼ 0.025) and anterior center-edge angle (39 vs. 34 , p ¼ 0.038) were greater in diabetics than controls. MRI and intraoperative findings indicated that more diabetics demonstrated evidence of femoral head chondromalacia compared to controls (57% vs. 8%, p ¼ 0.05; 100% vs. 71%, p < 0.001, respectively). The correlation between diabetes and femoral head chondromalacia was positive (r ¼ 0.281, p < 0.001). Acetabular chondromalacia prevalence and grade were similar between the groups on operative findings. Acetabular (369 vs. 389, p ¼ 0.842) and femoral head CMI (510 vs. 354, p ¼ 0.081) did not vary significantly between diabetics and controls. Femoral head CMI positively correlated with acetabular CMI (r ¼ 0.398, p < 0.001). Discussion and Conclusion: Our results support our hypothesis that hip chondral pathology is more prevalent in diabetics compared to a similar cohort of non-diabetic patients. However, this difference did not translate to severity of the defect between the groups. Pre-clinical studies have demonstrated that elevated blood glucose levels adversely affect chondrocyte metabolism, leading to destruction of joint cartilage. The deficits in range of motion exhibited by diabetic patients suggest soft tissue involvement about the hip joint. Further histological and molecular studies may better delineate the pathologic process that leads to hip pain in diabetic patients.
